Aethlon Medical Unveils Second Quarter Fiscal 2027 Financial Results Alongside a Comprehensive Corporate Update

SAN DIEGO, Nov. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal second quarter ended September 30, 2026, and provided a corporate update.